Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) — Cash Flow Quality Index
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Cash Flow Quality Index of 0.33x as of December 2023. Operating cash flow of CN¥90.45 Million is below net income of CN¥271.97 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Hangzhou Bio-Sincerity Pharma-Tech Co.Lt balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Cash Flow Quality Index (2019–2023)
Historical Cash Flow Quality Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hangzhou Bio-Sincerity Pharma-Tech Co.Lt tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2023)
Year-by-year earnings quality comparison for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. For live market cap and the full company financial profile, see Hangzhou Bio-Sincerity Pharma-Tech Co.Lt stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.33x | CN¥90.45 Million | CN¥271.97 Million | ▼ -75.1% |
| 2022 | 1.34x | CN¥259.41 Million | CN¥194.16 Million | ▲ +2.0% |
| 2021 | 1.31x | CN¥145.42 Million | CN¥110.97 Million | ▲ +38.4% |
| 2020 | 0.95x | CN¥54.36 Million | CN¥57.40 Million | ▼ -41.2% |
| 2019 | 1.61x | CN¥71.47 Million | CN¥44.40 Million | — |